Magnitude of dyslipidemia in type 2 diabetes
Background: Dyslipidemia in diabetes is very common and important contributing factor behind cardiovascular disease. This study shows the magnitude of dyslipidemia in type 2 diabetes whose glycemic control is optimal. Methodology: One hundred and thirty type 2 diabetes individuals with HbA1c <7%...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wolters Kluwer Medknow Publications
2022-05-01
|
| Series: | Annals of Medical Science and Research |
| Subjects: | |
| Online Access: | https://journals.lww.com/10.4103/amsr.amsr_29_22 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Summary: | Background:
Dyslipidemia in diabetes is very common and important contributing factor behind cardiovascular disease. This study shows the magnitude of dyslipidemia in type 2 diabetes whose glycemic control is optimal.
Methodology:
One hundred and thirty type 2 diabetes individuals with HbA1c <7% who were not on statin, were included in this study. Fasting lipid profile was estimated. Demographic characters and risk factors were recorded.
Results:
The mean age, duration of diabetes, and body mass index were 46.88 ± 9.32, 4.43 ± 4.58, and 24.54 ± 3.44, respectively. The prevalence of dyslipidemia was 88.46% in our study group. The most common pattern of dyslipidemia was combined dyslipidemia (46.1%) followed by isolated dyslipidemia (36.5%).
Conclusion:
The prevalence of dyslipidemia is very high despite good glycemic control in type 2 diabetes. |
|---|---|
| ISSN: | 2949-785X |